Ushbu ishga iqtibos qilgan ishlar

2 ta ish

Ish: The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic Hyperplasia

1. Placebo-Controlled Dose-Ranging Phase 2 Study of Subcutaneously Administered LHRH Antagonist Cetrorelix in Patients with Symptomatic Benign Prostatic Hyperplasia

   F.M.J. Debruyne, A A Gres, D. Arustamov

   MaqolaUrinary Bladder and Prostate ResearchEuropean Urology20081 iqtibos

   ABIABI:AkademIndex/openalex/2008.article.000044

2. Nafarelin

   Paul Chrisp, Karen L. Goa

   MaqolaEndometriosis Research and TreatmentDrugs19900 iqtibos

   ABIABI:AkademIndex/openalex/1990.article.000222